Osama Abdel Mohimen Mohamed

Spécialisation: Oncologist/mammologist
18 années d'expérience
Parle:
Arabic, English
Consultations en ligne : disponibles
Espace de travail: Egypte, Caire, Hôpitaux oncologiques internationaux Shefaa Al Orman
Leads a hematology unit and is a member of ESMO, ASBMT, and ASH.
Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.
- Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
- Manages aggressive acute leukemia and chronic blood disorders.
- Treats complications arising from various solid tumors.
- Works at an ESMO-accredited center that handles 6,000 patients annually.

Explorez les forfaits avec le Dr Osama Abdel Mohimen Mohamed

Sélectionner la procédure

greffe de moelle osseuse

$15,000

par package

Le forfait comprend une gamme standard de services médicaux proposés par la clinique ainsi que des avantages supplémentaires comme l'hébergement, le transfert, etc.

Consultation en ligne avec Osama Abdel Mohimen Mohamed

Pratique et facile

100 % sécurisé et confidentiel

$50

Services du médecin

Où en sommes-nous ?

1 de 3

Les détails sur ce médecin sont exhaustifs et clairs

Fortement en désaccord

Fortement d’accord

Qualifications

Dr. Osama Abdel Mohimen Mohamed is the Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is a physician in medical oncology and hematology. He characterizes his practice by a focus on aggressive blood cancers. Also, he is a member of the European Society of Medical Oncology (ESMO). He is also a member of the American Society of Hematology and the American Society of Bone Marrow Transplantation.

Specialization in Hematology and Oncology

Dr. Mohamed diagnoses and treats blood and bone marrow disorders. He treats acute and chronic leukemia, including cases requiring intensive chemotherapy or long-term oral therapies. The specialist also treats lymphatic system cancers and plasma cell disorders such as myeloma. For eligible myeloma patients, he uses combinations of novel agents and stem cell transplantation.

His clinical focus includes:

Myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) — disorders affecting the production of blood cells in the bone marrow
High-grade lymphomas requiring tailored treatment protocols
Management of complications arising from all types of solid tumors
Advanced chemotherapy and immunotherapy protocols

Professional Background

Dr. Mohamed is a consultant in medical oncology and hematology at Shefa El Orman Hospital. Previously, he worked at the National Cancer Institute of Cairo University. He served as a resident, demonstrator, and assistant lecturer during his tenure there. He also held specialist positions at Al Salam International Hospital, Baheya Oncology Center, and Al Molalmen Hospital.

2019–Present: Oncology and Hematology Consultant, Shefa El Orman Hospital (NGO), Luxor
2016–2019: Medical Oncology Specialist, Shefa El Orman Hospital (NGO), Luxor
2015–2016: Medical Oncology Specialist, BAHEYA Oncology Center (NGO)
2014–2022: Assistant Lecturer of Medical Oncology, National Cancer Institute, Cairo University
2011–2016: Medical Oncology Specialist, Al Salam International Hospital
2011–2014: Demonstrator of Medical Oncology, National Cancer Institute
2011–2013: Medical Oncology Specialist, Al Molalmen Hospital
2008–2010: Medical Oncology Resident, National Cancer Institute

Education and Early Training

Dr. Mohamed completed his initial medical training between 2006 and 2007 as a house officer at Kasr El Ainy Hospital. This rotation included service in the emergency department, intensive care, and general surgery. His rotation also covered pediatrics, obstetrics, gynecology, and general medicine. His academic career is rooted in Cairo University, where he contributed to oncology education.

Professional Memberships

The doctor belongs to several international scientific organizations that set treatment standards.

European Society of Medical Oncology (ESMO), member since 2008
American Society of Bone Marrow Transplantation (ASBMT), member since 2009
American Society of Hematology (ASH), member since 2010